3.8 Article

Promise of Real-World Evidence for Patient Centricity in Gulf Cooperation Council Countries: Call to Action

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medical Informatics

Bridging the Gap Between RCTs and RWE Through Endpoint Selection

Robert J. LoCasale et al.

Summary: This commentary discusses the value in bridging the industry disconnect between RTCs and RWE to promote the use of RWE in the RCT environment. It explores RCT endpoints along several axes including their clinical relevance and direct patient benefit, comparing them with their real-world counterparts to identify suitable paths or gaps for assimilating RWE endpoints into the RCT environment.

THERAPEUTIC INNOVATION & REGULATORY SCIENCE (2021)

Review Pharmacology & Pharmacy

Current Status, Challenges, and Future Perspectives of Real-World Data and Real-World Evidence in Japan

Katsutoshi Hiramatsu et al.

Summary: This article discusses the current status, challenges, and future developments of real-world data (RWD) and real-world evidence (RWE) in Japan. Challenges include restricted access and linkage of RWD, as well as a lack of universally accepted methodological approaches, impacting the potential benefits for patients and healthcare. Improvements in RWD access and data linkage are expected to lead to increased acceptance by decision-makers in Japan.

DRUGS-REAL WORLD OUTCOMES (2021)

Editorial Material Public, Environmental & Occupational Health

COVID-19 in the Middle East and North Africa region: an urgent call for reliable, disaggregated and openly shared data

Sarah Wehbe et al.

BMJ GLOBAL HEALTH (2021)

Review Oncology

Use of real-world evidence for oncology clinical decision making in emerging economies

Fernando Petracci et al.

Summary: Randomized clinical trials have long been the gold standard for new medical therapies, but with the increasing availability of patient level data, real-world evidence (RWE) is playing an important role in guiding clinical decision making in oncology. While RWE generation has been prolific in the USA and western Europe, there are still untapped opportunities in emerging economies due to structural and behavioral barriers.

FUTURE ONCOLOGY (2021)

Article Health Care Sciences & Services

What local experts expect from a health technology assessment (HTA) entity in Saudi Arabia: workshop conclusions

Hussain Abdulrahman Al-Omar et al.

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2020)

Article Public, Environmental & Occupational Health

Real-world data in Saudi Arabia: Current situation and challenges for regulatory decision-making

Fatemah A. Alnofal et al.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2020)

Review Pharmacology & Pharmacy

The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia

Jonathan Webster et al.

CLINICAL THERAPEUTICS (2019)

Review Oncology

Real-world data: towards achieving the achievable in cancer care

Christopher M. Booth et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Article Oncology

The Contribution of Cancer Surveillance Toward Real World Evidence in Oncology

Lynne Penberthy et al.

SEMINARS IN RADIATION ONCOLOGY (2019)

Article Health Care Sciences & Services

Use of real-world evidence for healthcare decision-making in the Middle East: practical considerations and future directions

Kasem S. Akhras et al.

EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH (2019)

Editorial Material Genetics & Heredity

A 1000 Arab genome project to study the Emirati population

Mariam Al-Ali et al.

JOURNAL OF HUMAN GENETICS (2018)

Review Pharmacology & Pharmacy

The positive impacts of Real-World Data on the challenges facing the evolution of biopharma

John Wise et al.

DRUG DISCOVERY TODAY (2018)

Article Oncology

The use of real-world data in cancer drug development

E. Skovlund et al.

EUROPEAN JOURNAL OF CANCER (2018)

Article Oncology

Real-world Data for Clinical Evidence Generation in Oncology

Sean Khozin et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)

Article Pharmacology & Pharmacy

European healthcare systems readiness to shift from 'one-size fits all' to personalized medicine

Sebastian Schee Genannt Halfmann et al.

PERSONALIZED MEDICINE (2017)

Article Oncology

Real-world Data for Clinical Evidence Generation in Oncology

Sean Khozin et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)

Review Medicine, Research & Experimental

Personalized medicine could transform healthcare

Sunil Mathur et al.

BIOMEDICAL REPORTS (2017)

Article Multidisciplinary Sciences

Limited Generalizability of Registration Trials in Hepatitis C: A Nationwide Cohort Study

Floor A. C. Berden et al.

PLOS ONE (2016)

Article Infectious Diseases

Cost effectiveness of a pentavalent rotavirus vaccine in Oman

Salah Thabit Al Awaidy et al.

BMC INFECTIOUS DISEASES (2014)

Article Endocrinology & Metabolism

Personalized oncology: Recent advances and future challenges

Madhu Kalia

METABOLISM-CLINICAL AND EXPERIMENTAL (2013)

Article Medicine, General & Internal

Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer

Sunil Verma et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)